SCHEMBL12011852

SCHEMBL12011852

c1ccc(-c2cc(-c3ccc(-n4c5ccccc5c5cnccc54)cc3)cc(-c3ccc4ccc5cccc6ccc3c4c56)n2)nc1

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK14 Q16539 1/20 0.32
▸ MAPT P10636 1/20 0.31
▸ MAOA P21397 4/20 0.31
▸ MAOB P27338 4/20 0.31
▸ ACHE P22303 1/20 0.31
▸ SLC2A1 P11166 1/20 0.31
▸ HTR2C P28335 1/20 0.31
▸ CCR1 P32246 2/20 0.30
▸ CCR5 P51681 2/20 0.30
▸ CCR8 P51685 2/20 0.30
▸ KDM4E B2RXH2 1/20 0.30
▸ LMNA P02545 1/20 0.30
▸ TP53 P04637 1/20 0.30
▸ ALPL P05186 1/20 0.30
▸ HSP90AA1 P07900 1/20 0.30
▸ ALPI P09923 1/20 0.30
▸ ALPG P10696 1/20 0.30
▸ ALOX15 P16050 1/20 0.30
▸ MAPK1 P28482 1/20 0.30
▸ HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12011851 0.94 MAPT (0.33) MAPK14MAPTSLC2A1HTR2CCCR1
SCHEMBL12011848 0.93 MAPT (0.31) MAPK14MAPTMAOAMAOBACHE
SCHEMBL3319777 0.90 HTR2C (0.39) MAPK14MAPTMAOAMAOBACHE
SCHEMBL13006466 0.89 MAPT (0.38) MAPK14MAPTMAOAMAOBACHE
SCHEMBL13006469 0.87 MAPK14 (0.32) MAPK14MAPTMAOAMAOBACHE
SCHEMBL12011849 0.87 MAPK14 (0.33) MAPK14SLC2A1HTR2CCCR1CCR5
SCHEMBL12011859 0.86 GRM5 (0.35) MAPK14MAPTSLC2A1HTR2CMCL1
SCHEMBL12011856 0.86 GRM5 (0.33) MAPK14MAPTMAOAMAOBACHE
SCHEMBL3315957 0.86 CYP11B1 (0.38) MAPTMAOAMAOBACHECCR1
SCHEMBL12919234 0.86 MAOA (0.35) MAOAMAOBACHEKDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2128159-B1 COMPOUND WHEREIN SUBSTITUTED BIPYRIDYL GROUP IS CONNECTED WITH PYRIDOINDOLE RING STRUCTURE THROUGH PHENYLENE GROUP, AND ORGANIC ELECTROLUMINESCENT DEVICE HODOGAYA CHEMICAL CO LTD (JP) 2017-08-16 — — EP disclosed
US-8252431-B2 Compound wherein substituted bipyridyl group is connected with pyridoindole ring structure through phenylene group, and organic electroluminescent device HODOGAYA CHEMICAL CO., LTD. (JP) 2012-08-28 — — US disclosed
US-8252431-B2 Compound wherein substituted bipyridyl group is connected with pyridoindole ring structure through phenylene group, and organic electroluminescent device HODOGAYA CHEMICAL CO., LTD. (JP) 2012-08-28 — — US disclosed
US-20100123388-A1 COMPOUND WHEREIN SUBSTITUTED BIPYRIDYL GROUP IS CONNECTED WITH PYRIDOINDOLE RING STRUCTURE THROUGH PHENYLENE GROUP, AND ORGANIC ELECTROLUMINESCENT DEVICE HODOGAYA CHEMICAL CO., LTD. (JP) 2010-05-20 — — US disclosed
US-20100123388-A1 COMPOUND WHEREIN SUBSTITUTED BIPYRIDYL GROUP IS CONNECTED WITH PYRIDOINDOLE RING STRUCTURE THROUGH PHENYLENE GROUP, AND ORGANIC ELECTROLUMINESCENT DEVICE HODOGAYA CHEMICAL CO., LTD. (JP) 2010-05-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100123388-A1 COMPOUND WHEREIN SUBSTITUTED BIPYRIDYL GROUP IS CONNECTED WITH PYRIDOINDOLE RING STRUCTURE THROUGH PHENYLENE GROUP, AND ORGANIC ELECTROLUMINESCENT DEVICE SLCO4C1, PNPO, EPHA1 MAPK14 1808/4885MAPT 1944/4885MAOA 332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback